ADVANCES IN THERAPY

期刊基本信息

  • 期刊名称:ADVANCES IN THERAPY
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore)
  • 期刊ISSN:0741-238X
  • 期刊EISSN:1865-8652
  • 简称:ADV THER
  • 影响因子:4
  • 实时影响因子:截止2025年5月19日:4.03
  • 五年影响因子:4.2
  • JCI期刊引文指标:0.84
  • h-index:53
  • 2024-2025自引率:2.50%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:https://www.editorialmanager.com/adth
  • 是否OA开放访问:No
  • 出版商:Springer Healthcare
  • 出版年份:2000

ADVANCES IN THERAPY

Science Citation Index Expanded (SCIE)Scopus (CiteScore)

期刊介绍

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

期刊语言要求

Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

投稿要求

CITESCORE

CiteScoreSJRSNIPCiteScore排名
7.201.2361.380
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q149 / 275
82%

WOS期刊JCR分区

WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ261/195
69%
学科:PHARMACOLOGY & PHARMACYSCIEQ182/352
76.8%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ267/195
65.9%
学科:PHARMACOLOGY & PHARMACYSCIEQ2107/353
69.83%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区3区4区
PHARMACOLOGY & PHARMACY
药学
1区1区2区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区1区3区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 4区3区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
2区1区3区
PHARMACOLOGY & PHARMACY
药学
1区4区3区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友